Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Antibiotics specialty page provides antibiotics-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Oral Antibiotic Compliance for ABSSSI
Panelists emphasize the importance of patient education, patient compliance, oral antibiotic adherence, and managing expectations of prescriptions for acute bacterial skin and skin structure infections.
New or Upcoming Treatment Options for MDR Bacteria
Jason Gallagher, PharmD, discusses the recently approved agents and agents in late stage development for multidrug-resistant bacteria and their potential role in treatment.
Resistance Issues and Resistance Factors With MDR Bacteria
Jason Gallagher, PharmD, provides an overview of the resistance issues and resistance factors of specific pathogens that develop multidrug resistance.
Understanding the Prevalence of ABSSSI in the Community
Panelists discuss the prevalence of acute bacterial skin and skin structure infections, including MRSA, in the community, as well as risk factors, susceptibility, and increased resistance to oral antibiotics such as Keflex.
Pseudomonas Infections: Selecting Upfront Antibiotics
Panelists reflect on their personal upfront approaches to treating Pseudomonas infections before lab results return, considering monotherapy versus treatment cocktails and the inherent risks that need to be accounted for.  
Initial Therapy for MDR Bacteria and Antibiotic Resistance
Jason Gallagher, PharmD, discusses the importance of appropriate initial therapy and the mechanism of resistance of multidrug-resistant bacteria.
Why Might Hospital Length-of-Stay Be Shorter in Patients on a Fluoroquinolone?
Chelsea Drennan, PharmD(c) explains why hospital length-of-stay might be shorter in patients who are on a fluoroquinolone versus a beta-lactam.
<i>Pseudomonas</i> Infections: Optimizing Diagnostic Strategies
Panelists provide considerations for the optimal approaches to diagnosing Pseudomonas infections and identify where imaging and rapid diagnostics fit into the paradigm.
Big advances in treatment can